149 related articles for article (PubMed ID: 37551918)
21. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
[TBL] [Abstract][Full Text] [Related]
22. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
[TBL] [Abstract][Full Text] [Related]
23. Non-small Cell Lung Cancer (NSCLC) in Octogenarians in Clinical Practice.
Koyi H; Hillerdal G; Kölbeck KG; Brodin D; Liv P; Brandén E
Anticancer Res; 2016 Oct; 36(10):5397-5402. PubMed ID: 27798905
[TBL] [Abstract][Full Text] [Related]
24. Comparative analysis between combination and single-agent chemotherapy for elderly patients with advanced non-small cell lung cancer: A nationwide population-based outcome study.
Lee YG; Lee JH; Kim SH; Kim YJ; Lee H; Ahn S; Jang JS; Lee JS; Kim JH
Lung Cancer; 2018 Aug; 122():88-93. PubMed ID: 30032852
[TBL] [Abstract][Full Text] [Related]
25. Non-small cell lung cancer in very young and very old patients.
Kuo CW; Chen YM; Chao JY; Tsai CM; Perng RP
Chest; 2000 Feb; 117(2):354-7. PubMed ID: 10669674
[TBL] [Abstract][Full Text] [Related]
26. Survival and Racial Differences of Non-Small Cell Lung Cancer in the United States Military.
Brzezniak C; Satram-Hoang S; Goertz HP; Reyes C; Gunuganti A; Gallagher C; Carter CA
J Gen Intern Med; 2015 Oct; 30(10):1406-12. PubMed ID: 25805503
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients.
Fiteni F; Vernerey D; Bonnetain F; Vaylet F; Sennélart H; Trédaniel J; Moro-Sibilot D; Herman D; Laizé H; Masson P; Derollez M; Clément-Duchêne C; Milleron B; Morin F; Zalcman G; Quoix E; Westeel V
Eur J Cancer; 2016 Jan; 52():120-8. PubMed ID: 26682871
[TBL] [Abstract][Full Text] [Related]
28. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of age at diagnosis among young non-small cell lung cancer patients under 40 years old: a population-based study.
Liu M; Cai X; Yu W; Lv C; Fu X
Oncotarget; 2015 Dec; 6(42):44963-70. PubMed ID: 26517681
[TBL] [Abstract][Full Text] [Related]
30. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
[TBL] [Abstract][Full Text] [Related]
31. The effect of tumor laterality on survival for non-small cell lung cancer patients treated with radiotherapy.
Jørgensen N; Meline EL; Jeppesen SS; Hansen O; Nielsen M; Schytte T
Acta Oncol; 2019 Oct; 58(10):1393-1398. PubMed ID: 31271075
[No Abstract] [Full Text] [Related]
32. Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.
Yao ZH; Liao WY; Ho CC; Chen KY; Shih JY; Chen JS; Lin ZZ; Lin CC; Chih-Hsin Yang J; Yu CJ
Oncologist; 2017 Sep; 22(9):1075-1083. PubMed ID: 28507206
[TBL] [Abstract][Full Text] [Related]
33. Treatment Patterns and Differences in Survival of Non-Small Cell Lung Cancer Patients Between Academic and Non-Academic Hospitals in the Netherlands.
van der Linden N; Bongers ML; Coupé VMH; Smit EF; Groen HJM; Welling A; Schramel FMNH; Uyl-de Groot CA
Clin Lung Cancer; 2017 Sep; 18(5):e341-e347. PubMed ID: 28347579
[TBL] [Abstract][Full Text] [Related]
34. Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: a prospective population-based study.
Wanders R; Steevens J; Botterweck A; Dingemans AM; Reymen B; Baardwijk Av; Borger J; Bootsma G; Pitz C; Lunde R; Geraedts W; Lambin P; De Ruysscher D
Eur J Cancer; 2011 Dec; 47(18):2691-7. PubMed ID: 21733675
[TBL] [Abstract][Full Text] [Related]
35. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database.
Mery CM; Pappas AN; Bueno R; Colson YL; Linden P; Sugarbaker DJ; Jaklitsch MT
Chest; 2005 Jul; 128(1):237-45. PubMed ID: 16002941
[TBL] [Abstract][Full Text] [Related]
36. Variable impact of prior cancer history on the survival of lung cancer patients.
Monsalve AF; Hoag JR; Resio BJ; Chiu AS; Brown LB; Detterbeck FC; Blasberg JD; Boffa DJ
Lung Cancer; 2019 Jan; 127():130-137. PubMed ID: 30642541
[TBL] [Abstract][Full Text] [Related]
37. Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancer.
Coate LE; Massey C; Hope A; Sacher A; Barrett K; Pierre A; Leighl N; Brade A; de Perrot M; Waddell T; Liu G; Feld R; Burkes R; Cho BC; Darling G; Sun A; Keshavjee S; Bezjak A; Shepherd FA
J Thorac Oncol; 2011 Mar; 6(3):537-44. PubMed ID: 21258243
[TBL] [Abstract][Full Text] [Related]
38. Comparison of survival and hospitalization rates between Medicare patients with advanced NSCLC treated with bevacizumab-carboplatin-paclitaxel and carboplatin-paclitaxel: a retrospective cohort study.
Langer C; Ravelo A; Hazard SJ; Guerin A; Ionescu-Ittu R; Latremouille-Viau D; Wu EQ; Ramalingam S
Lung Cancer; 2014 Dec; 86(3):350-7. PubMed ID: 25439437
[TBL] [Abstract][Full Text] [Related]
39. The influence of hormone replacement therapy on lung cancer incidence and mortality.
Titan AL; He H; Lui N; Liou D; Berry M; Shrager JB; Backhus LM
J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1546-1556.e4. PubMed ID: 31866083
[TBL] [Abstract][Full Text] [Related]
40. Palliative care and psychosocial care in metastatic non-small cell lung cancer: factors affecting utilisation of services and impact on patient survival.
Duggan KJ; Wiltshire J; Strutt R; Boxer MM; Berthelsen A; Descallar J; Vinod SK
Support Care Cancer; 2019 Mar; 27(3):911-919. PubMed ID: 30066201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
